HIVEP3 and acute myeloid leukemia: The forest plots represented the prognostic significance of augmented HIVEP3 expression for dismal outcomes of AML patients (HR = 1.4; 95% (CI), 1.07–1.7; p = 0.011), independent of age, poor cytogenetic risk, and specific gene mutations (Figure 3A and Figure S1).